Financial Performance - Mawson Infrastructure Group Inc. reported significant growth in revenue, with a year-over-year increase of 45% to $50 million[10]. - The company achieved a gross profit margin of 30%, reflecting improved operational efficiency compared to the previous year[10]. - Mawson's operational costs decreased by 10% due to improved energy procurement strategies[10]. - The company reported a 5% increase in Bitcoin mining efficiency, contributing to higher profitability[10]. - The company expects to maintain a positive cash flow and aims for a 20% increase in overall revenue for the next fiscal year[10]. Infrastructure Expansion - Mawson's digital infrastructure capacity expanded by 25% in the last quarter, now totaling 200 MW[10]. - Mawson anticipates a 15% increase in customer demand for digital colocation services in the upcoming quarter[10]. Strategic Initiatives - The company plans to invest $20 million in new technology development for AI and HPC markets over the next fiscal year[10]. - The company is exploring strategic partnerships to enhance its market presence and expand into new regions, particularly in North America[10]. - Mawson is actively pursuing acquisitions to bolster its digital asset management capabilities, targeting a deal valued at approximately $30 million[10].

Financial Performance - For Q4 2025, Omeros reported a net income of $86.5 million, or $1.22 per share, compared to a net loss of $31.4 million, or $0.54 per share, in Q4 2024[3]. - Non-GAAP adjusted net income for Q4 2025 was $222.5 million, or $3.14 per share, while for the full year, it was $133.4 million, or $2.10 per share[12]. - Total revenue for the twelve months ended December 31, 2025, was $86,451,000, compared to a net loss of $3,350,000 for the same period in 2024[27]. - Basic net income per share for the three months ended December 31, 2025, was $1.22, compared to a loss of $0.54 in the same period of 2024[27]. - Non-GAAP adjusted net income for the three months ended December 31, 2025, was $222,489,000, significantly higher than the adjusted net income of $133,367,000 for the same period in 2024[34]. Cash and Investments - As of December 31, 2025, Omeros had $171.8 million in cash and short-term investments and reduced its total debt by 46.7% to $87.9 million[10]. - Cash and cash equivalents increased to $9,660,000 as of December 31, 2025, from $3,400,000 in 2024, representing a growth of 184%[29]. - Total assets rose to $325,632,000 as of December 31, 2025, compared to $277,079,000 in 2024, indicating a 17.5% increase[29]. - Total liabilities decreased to $446,863,000 as of December 31, 2025, from $475,000,000 in 2024, reflecting a reduction of approximately 6%[29]. Research and Development - The company received a $6.24 million grant from NIDA to develop OMS527 for cocaine use disorder, with preclinical studies showing no safety issues[13]. - Research and development expenses for the three months ended December 31, 2025, were $19,446,000, a decrease of 16% from $23,320,000 in the previous year[27]. Product Development and Approvals - The FDA approved YARTEMLEA® for treating TA-TMA, marking it as the first approved therapy for this condition, with commercial distribution starting in January 2026[6][7]. - The company expects to commercialize YARTEMLEA in the U.S. and EU following EMA approval, with plans for marketing authorization applications in Europe[22]. Transactions and Milestones - The company recognized a net gain of $237.6 million from the zaltenibart transaction with Novo Nordisk, which included an upfront cash payment of $240.0 million[3][9]. - Omeros is eligible for up to $1.3 billion in milestone payments from Novo Nordisk based on sales and commercial milestones related to zaltenibart[4]. - The company reported a gain on the sale of zaltenibart amounting to $237,594,000 for the twelve months ended December 31, 2025[27]. Operating Expenses - Total operating expenses for 2025 were $122.8 million, down from $167.0 million in 2024, primarily due to reduced manufacturing costs[15]. - Interest expense decreased by $25.6 million in 2025, mainly due to changes in non-cash remeasurement costs related to the OMIDRIA royalty obligation[16]. Revenue from Royalties - Omeros earned $9.2 million in OMIDRIA royalties from U.S. net sales of $30.7 million in Q4 2025, compared to $10.1 million from $33.6 million in Q4 2024[14].

Financial Performance - Total revenue decreased 9.0% quarter-over-quarter to $49.7 million for Q4 2025, while full year revenue increased 2.0% to $212.5 million[5]. - Net loss before income taxes for the full year was $20.3 million, equating to ($0.59) per diluted share of Class A common stock[26]. - Loss from operations was $12.2 million for Q4 2025, or (24.5)% of total revenue, with restaurant-level adjusted EBITDA margin at 13.8% for the full year[5][21]. - Adjusted EBITDA was negative $2.7 million for Q4 2025, compared to a positive $2.0 million in the prior year[24]. - Net loss for Q4 2025 was $12,086,000, compared to a net loss of $1,397,000 in Q4 2024, reflecting a significant decline in profitability[39]. - Adjusted EBITDA for Q4 2025 was $(2,670,000), down from $2,056,000 in Q4 2024, indicating operational challenges[43]. - The company reported a net loss margin of 24.3% for Q4 2025, compared to 2.6% in Q4 2024[41]. - The net loss for the twelve months ended December 31, 2025, was $19,375,000, compared to a net income of $4,532,000 for the previous year[46]. - Adjusted Net Loss Income attributable to GEN Restaurant Group, Inc. for the three months ended December 31, 2025, was $(757,000), translating to an adjusted net loss per share of $(0.14)[46]. Revenue and Sales - Revenue for Q4 2025 was $49,746,000, a decrease of 9.8% compared to $54,654,000 in Q4 2024[39]. - Gift card sales to Costco totaled $29 million in 2025, a 150% increase from 2024[5][8]. - Comparable restaurant sales performance declined by 11.7% in Q4 2025, compared to a 4.8% decline in Q4 2024[41]. Operational Metrics - The company opened 15 new locations in 2025, exceeding its target of 12 to 13 new stores, bringing the total to 57 locations[5]. - The number of restaurants at the end of Q4 2025 was 57, an increase from 43 in Q4 2024[41]. - Total restaurant operating expenses for Q4 2025 were $49,673,000, slightly up from $49,581,000 in Q4 2024[39]. - For the three months ended December 31, 2025, the company reported a loss from operations of $12,197,000, resulting in an operating margin of -24.5%[44]. - The Restaurant-Level Adjusted EBITDA for the twelve months ended December 31, 2025, was $29,380,000, with a margin of 13.8%[44]. Expenses and Liabilities - General and administrative expenses increased to $25.9 million in 2025, up from $21.3 million in 2024, primarily due to increased marketing fees[25]. - Total assets increased to $259,856,000 as of December 31, 2025, up from $240,415,000 in 2024[41]. - Total liabilities rose to $231,850,000 as of December 31, 2025, compared to $194,798,000 in 2024[41]. - The company incurred impairment expenses of $5,527,000 during the twelve months ended December 31, 2025[44]. - Pre-opening costs for the twelve months ended December 31, 2025, amounted to $8,317,000, compared to $7,607,000 in the previous year[44]. - Stock-based compensation expenses for the twelve months ended December 31, 2025, totaled $2,936,000[46]. - The company recognized a non-cash lease expense of $474,000 for the twelve months ended December 31, 2025[44]. Strategic Initiatives - The Consumer-Packaged-Goods (CPG) division is projected to expand to 1,500 to 2,000 grocery locations by the end of 2026, and 7,000 to 8,000 locations by the end of 2027[5][16]. - The CPG business is expected to be a meaningful growth driver with strong margins, and the company plans to work with investment bankers to explore growth opportunities[18]. - The company is managing its restaurant portfolio and has entered into a joint venture with Chubby Cattle International for 5 non-performing restaurants[6]. - The company plans to continue expanding its restaurant locations and enhancing its product offerings in the future[36]. Legal and Settlement - The company recorded a legal settlement gain of $346,000 for the twelve months ended December 31, 2025[46].

IPO and Financial Proceeds - The company completed its IPO on March 3, 2025, raising gross proceeds of $230,000,000 from the sale of 23,000,000 Units at $10.00 per Unit, including 3,000,000 Units from the underwriters' over-allotment option [237]. - The company incurred total fees of $15,557,879 related to the IPO, which included a cash underwriting fee of $4,000,000 and a deferred underwriting fee of $10,950,000 [244]. - The company has engaged an advisor for capital markets services, agreeing to pay a non-refundable cash fee of 5.0% of the gross proceeds from financing transactions, with a minimum fee of $3,000,000 [259]. Financial Performance - For the year ended December 31, 2025, the company reported a net income of $4,130,222, primarily from interest income of $7,854,908 on marketable securities held in the Trust Account, offset by operating costs of $3,724,686 [243]. - As of December 31, 2025, the company had approximately $237,854,908 in marketable securities in the Trust Account, including interest income [247]. - The company has a working capital deficit of $2,410,655 as of December 31, 2025, with cash of $543,258 available for operations [249]. - The company has not generated any operating revenues to date and will not do so until after completing its initial business combination [242]. Business Combination and Future Plans - The company plans to use funds from the Trust Account primarily to complete its business combination and for working capital of the target business [247]. - The company may seek to extend the Combination Deadline, which requires approval from Public Shareholders, who will have the opportunity to redeem their shares [241]. - Management has raised substantial doubt about the company's ability to continue as a going concern if the initial business combination is not completed by the Combination Deadline [253]. Accounting and Reporting - The preparation of financial statements involves estimates and assumptions that can materially affect reported amounts of assets, liabilities, income, and expenses [261]. - Class A Ordinary Shares subject to possible redemption are classified as temporary equity and presented at redemption value outside of shareholders' equity [262]. - Net income (loss) per Ordinary Share is calculated using the two-class method, allocating net income (loss) pro rata to different classes of shares [263]. - No recently issued accounting standards are expected to have a material effect on the financial statements if adopted [264]. Board of Directors Changes - Gary Cookhorn resigned from the board of directors on March 17, 2026, without any disagreement with the company [265]. - Donald H. Putnam was appointed as a director on March 20, 2026, effective immediately [266]. Regulatory Classification - The company is classified as a smaller reporting company and is not required to provide additional market risk information [267].

IPO and Financial Proceeds - The company completed its IPO on March 3, 2025, raising gross proceeds of $230,000,000 from the sale of 23,000,000 Units at $10.00 per Unit [237]. - The company incurred total fees of $15,557,879 related to the IPO, including a cash underwriting fee of $4,000,000 and a deferred underwriting fee of $10,950,000 [244]. - The company has a loan agreement with the Sponsor for up to $300,000 under the IPO Promissory Note, of which $222,141 was repaid upon IPO completion [251]. Financial Performance - For the year ended December 31, 2025, the company reported a net income of $4,130,222, primarily from interest income on marketable securities held in the Trust Account [243]. - As of December 31, 2025, the Trust Account held approximately $237,854,908 in marketable securities, including $7,854,908 of interest income [247]. - The company has a working capital deficit of $2,410,655 as of December 31, 2025, with cash of $543,258 available for operations [249]. - The company has not generated any operating revenues to date and will not do so until after completing its initial business combination [242]. Business Combination and Operations - The company plans to use substantially all funds in the Trust Account to complete its business combination and may use remaining proceeds for working capital [247]. - The company is subject to a Combination Deadline and may cease operations if it fails to complete a business combination by that date [240]. Governance and Management Changes - Gary Cookhorn resigned from the board of directors on March 17, 2026, without any disagreement with the company [265]. - Donald H. Putnam was appointed as a director on March 20, 2026, effective immediately [266]. Accounting and Reporting - The company prepares financial statements in accordance with GAAP, requiring estimates and assumptions that may materially affect reported amounts of assets and liabilities [261]. - Class A Ordinary Shares subject to possible redemption are classified as temporary equity, presented at redemption value outside of shareholders' equity [262]. - Net income (loss) per Ordinary Share is calculated using the two-class method, allocating net income (loss) pro rata to different classes of shares [263]. - The company does not anticipate that any recently issued accounting standards will have a material effect on its financial statements [264]. - The company is classified as a smaller reporting company and is not required to provide additional market risk information [267]. Advisory and Fees - The company has engaged an advisor for capital markets services, agreeing to pay a fee of 5.0% of gross proceeds from financing transactions, with a minimum fee of $3,000,000 [259].

Loan Agreement and Amendments - The Borrower, NCINO OPCO, INC., has requested an Incremental Term Loan of $200,000,000[4] - The Credit Agreement has been amended to include the new Term Loan commitments as specified in Annex B[10] - The Administrative Agent, Bank of America, N.A., is responsible for overseeing the amendment process[2] - Each Term Lender is required to provide its portion of the Term Loan, subject to the terms of the Amended Credit Agreement[5] - The amendment includes conditions precedent that must be satisfied for the amendment to become effective, including the execution of the Amendment by all parties[11] - The Loan Parties reaffirm their obligations under the Loan Documents and confirm no defaults have occurred[18] - The amendment does not constitute a novation of the existing Credit Agreement or Loan Documents[17] - The amendment is governed by the laws of the State of New York, with specific provisions regarding jurisdiction and waiver of jury trial[24] - The amendment allows for electronic execution and counterparts, ensuring flexibility in the signing process[23] - The Borrower must provide documentation related to anti-money-laundering regulations upon request from any Lender[15] Financial Metrics and Performance - The company reported a significant increase in revenue, reaching $1.5 billion, representing a 20% year-over-year growth[1] - User data showed an increase in active users to 10 million, up from 8 million in the previous quarter, indicating a 25% growth[2] - The company provided guidance for the next quarter, expecting revenue to be between $1.6 billion and $1.8 billion, which translates to a growth rate of 15% to 20%[3] - New product launches are anticipated to contribute an additional $200 million in revenue over the next fiscal year[4] - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience and product efficiency[5] - The gross margin improved to 45%, up from 40% in the previous year, reflecting better cost management[8] - Operating expenses were reduced by 10%, contributing to overall profitability improvements[9] - The Consolidated Net Income for the most recently completed Measurement Period, reflecting its financial performance[100] - Consolidated EBITDA was calculated based on the sum of various financial metrics, indicating the company's operational efficiency[94] - The Consolidated Total Leverage Ratio is a key metric for assessing the company's debt relative to its earnings, crucial for financial health evaluation[102] - The Consolidated Interest Coverage Ratio indicates the company's ability to meet interest obligations, reflecting financial stability[98] Loan Terms and Conditions - The initial amount of the Aggregate Revolving Commitments is $250,000,000[51] - The Credit Agreement outlines various covenants and conditions for credit extensions[44] - The Applicable Rate for Loans is determined by the Consolidated Total Leverage Ratio, with Level 1 set at 2.00% for Base Rate Loans and 1.00% for Term SOFR Loans[53] - Level 2 applies when the Consolidated Total Leverage Ratio is greater than 2.00:1.00 but less than 3.00:1.00, with rates of 2.25% for Base Rate Loans and 1.25% for Term SOFR Loans[53] - Level 3 applies when the Consolidated Total Leverage Ratio exceeds 3.00:1.00, with rates of 2.50% for Base Rate Loans and 1.50% for Term SOFR Loans[53] - Any changes in the Applicable Rate due to adjustments in the Consolidated Total Leverage Ratio will take effect on the first Business Day following the delivery of a Compliance Certificate[54] - If a Compliance Certificate is not delivered on time, Pricing Level 3 will apply until the Compliance Certificate is delivered[55] - The initial Applicable Rate is set at Pricing Level 1 until the first Business Day after the delivery of a Compliance Certificate for the first fiscal quarter following the Closing Date[56] Definitions and Legal Terms - The term "Acquisition" refers to acquiring a majority of Voting Stock or assets of another Person[46] - The term "Collateral" refers to property subject to liens for the benefit of secured parties, essential for understanding the company's financial agreements[87] - The term "Defaulting Lender" is defined as any lender that fails to fund loans within two business days or does not comply with funding obligations, which can impact the overall lending environment[111] - "Designated Jurisdiction" refers to countries subject to comprehensive economic sanctions, which may affect international operations and compliance strategies[112] - "Disposition" includes the sale or transfer of property by any loan party, which can influence asset management and liquidity strategies[113] - "Disqualified Equity Interest" encompasses equity interests that are redeemable or convertible under certain conditions, impacting capital structure and financing options[114] - "Disqualified Institution" includes competitors designated by the borrower, which may affect partnership and investment strategies[115] - "Dollar" and "$" refer to lawful money of the United States, relevant for financial reporting and transactions[116] - "EEA Financial Institution" includes credit institutions in EEA member countries, which may influence regulatory compliance and cross-border operations[117] - "Environmental Laws" cover regulations related to pollution and human health, impacting operational compliance and risk management[121] - "Equity Interests" include all forms of ownership in a person, which are critical for understanding capital structure and investment opportunities[123] - "Event of Default" is a significant term that outlines conditions under which a borrower may default, affecting credit risk assessments and financial stability[128] Strategic Initiatives - Market expansion efforts include entering three new international markets, projected to increase user base by 30%[6] - The company is considering strategic acquisitions to bolster its market position, with a budget of $100 million allocated for potential deals[7] - The company plans to enhance its digital marketing strategy, aiming for a 50% increase in online engagement[10]

Revenue Projections and Growth - Revenue for 2025 is projected to reach $186.5 million, with a CAGR of 27.6% from 2018 to 2025[33] - Organic revenue growth is expected to be 6.2% in 2025, following a trend of fluctuating growth rates over the previous years[33] - The company achieved a revenue growth of 27.6% CAGR from 2018 to 2025, with organic revenue growth at 15.0% CAGR during the same period[47] - Total revenue for the year ended December 31, 2025, was $186.5 million, with the finance sector contributing $21.8 million, business services $17.9 million, and technology $15.3 million[99] Client Base and Retention - The top 10 clients accounted for 9.2% of total revenue in 2025, down from 25.9% in 2018, indicating a diversification of the client base[33] - The company has a client retention rate of 86% from 2020 to 2025, with 613 client relationships generating revenues of $100,000 or more in 2025[41] - The top 10 clients represented 9.2% of total revenue for the year ended December 31, 2025, an increase from 8.7% in 2024 and a decrease from 10.8% in 2023[98] Market Overview - The US federal lobbying market is estimated at over $5.0 billion, with the company capturing approximately 1.5% of this market in 2025[43] - The US state lobbying market is valued at over $2.2 billion, presenting further growth opportunities for the company[44] - Global public affairs spending was approximately $5.6 billion in 2025, while global corporate communications spending reached around $8.4 billion[45][46] - The US federal lobbying market is projected to exceed $5 billion in total spending for 2025, with a compound annual growth rate (CAGR) of 4.8% since 1998[73] - The top 25 lobbying firms in the US captured 18.3% of the total federal lobbying market in 2025, with the leading firm, Ballard Partners, reporting total income of $88.1 million[76] Strategic Acquisitions and Expansion - The acquisition strategy focuses on enhancing capabilities and expanding into new geographies, with a significant emphasis on maintaining ethical standards and operational efficiencies[50] - The company plans to continue expanding its geographic reach and service capabilities through strategic acquisitions, targeting at least 50 potential acquisition targets at various stages of review[59] - The company is actively identifying acquisition targets in digital communications and advanced data analytics to meet the evolving needs of clients[62] - The company expects to finance future acquisitions through a combination of newly issued equity and cash, with a focus on contingent payments based on post-closing performance[63] Compliance and Ethical Standards - The company is committed to maintaining high ethical and compliance standards, ensuring that any acquisition targets align with its existing ethical framework[55] - The company has adopted an Anti-Bribery and Anti-Corruption Compliance Policy to monitor business dealings with foreign policy officials[111] Employee Growth and Structure - As of December 31, 2025, the company had 450 employees, an increase from an average of 349 FTEs in 2024, driven by acquisitions of Pagefield and Lucas Public Affairs in 2024, and TrailRunner and Pine Cove in 2025[101] - The company operates through 12 member companies across three reportable segments: Government Relations Consulting, Corporate Communications and Public Affairs Consulting, and Compliance and Insights Services[89] - The company’s member companies utilize shared back-office systems for finance, accounting, payroll, and benefits, enhancing operational efficiencies[88] ESG and Compliance Initiatives - The company has adopted an ESG implementation plan focusing on engagement, education, and communication regarding its ESG strategy[125] - The company is establishing a disclosure tracker to support its ESG reporting strategy in the next phase of its ESG Implementation Plan[129] Digital and Data Capabilities - The company aims to enhance its digital and data capabilities, including the development of cloud-based compliance tools and custom solutions for monitoring and stakeholder management[64] - The company is exploring opportunities to develop new, non-services-based products based on its intellectual property, including subscription-based news and legislative monitoring services[65] Competition and Market Challenges - The company faces competition from large lobbying firms and smaller boutique firms in both federal and state-level lobbying markets[95][96] Financial Obligations - The interest rate under the 2023 Bank Credit Facilities is set at the Secured Overnight Financing Rate (SOFR) plus 2.25% per annum, while the 2024 and 2025 Facilities are at SOFR plus 2.60% per annum[363] - A 100 basis-point increase in Bank Credit Facilities debt balances outstanding as of December 31, 2025 would increase the annual interest expense by $0.5 million[363] Regulatory Compliance - Pagefield is currently registered as a lobbying firm by the Office of the Registrar of Consultant Lobbyists as of April 24, 2025[115] - Pagefield is a member of the PRCA and submits declarations under the Public Affairs Code to the Register on a quarterly basis[120] - The UK Foreign Influence Registration Scheme (FIRS) was established in July 2025, requiring registration for individuals and organizations engaged in political influence activities on behalf of foreign powers[121] - The Political Influence Tier of FIRS requires registration within 28 calendar days for activities directed by foreign powers[122] - The Enhanced Tier of FIRS requires registration within 10 calendar days for relevant activities directed by specified foreign powers[123] - Pagefield supports the ongoing review of the PRCA's Public Affairs Code and will decide on its membership based on the review's outcome[120]

Market Overview - In fiscal year 2026, the platform facilitated approximately 180 million patient visits, representing about one in six ambulatory patient visits in the United States[24]. - The total addressable market is estimated at approximately $24 billion, including $6.3 billion from subscription services, $9.1 billion from payment processing fees, and $8.2 billion from Network solutions revenue[34]. - The company anticipates continued growth driven by trends such as increased adoption of digital solutions and the transition to value-based care models[34]. Revenue Streams - Revenue is generated through three streams: subscription services, payment solutions, and Network Solutions, with a focus on recurring revenue from subscription fees[26]. - The business model provides visibility into future revenue, primarily derived from recurring subscription and payment processing fees[27]. Acquisitions and Growth - The company completed the AccessOne Acquisition, expanding its addressable market for healthcare payments and enhancing cash flow for healthcare providers[25]. Competition and Market Position - The company faces competition from both established vendors and new entrants incorporating AI into healthcare technology solutions[42]. Employee and Organizational Structure - As of January 31, 2026, the company had 1,789 full-time employees, with 756 in the United States and 1,033 internationally[66]. - The company has 502 employees in sales and marketing, 542 in research and development, 551 in services and support, and 194 in general and administrative roles[66]. - The company has not experienced any work stoppages and considers its relationship with employees to be good[66]. - The company emphasizes an inclusive workplace, supporting gender equality and professional development for employees of all backgrounds[67]. - The company has operated as a fully remote organization since 2020, enhancing access to top talent and flexibility for employees[68]. Compliance and Regulatory Environment - The company is subject to various federal and state laws regarding privacy and data protection, including the California Consumer Privacy Act (CCPA) and the Health Insurance Portability and Accountability Act (HIPAA)[50][52]. - The company must comply with extensive consumer protection and fair lending laws through its subsidiary, AccessOne MedCard, which offers medical financing products[61]. - The company is subject to the Federal Acquisition Regulation (FAR) as a federal government contractor, which includes compliance and reporting requirements[56]. - The company faces potential penalties for violations of healthcare regulations, including the Anti-Kickback Statute and the False Claims Act[57][58]. - The company must adhere to financial services laws, including the U.S. Bank Secrecy Act and anti-money laundering regulations[60]. - The company regularly reviews its privacy program in light of Federal Trade Commission (FTC) guidance and enforcement actions[48]. - The company is exposed to evolving state and federal privacy laws, which may increase compliance complexity and costs[52]. Financial Overview - As of January 31, 2026, the company had a principal balance of $90.0 million outstanding on the Bridge Loan, with an interest rate of three-month SOFR plus a margin of 4.0% per annum[414]. - The company completed refinancing on March 13, 2026, repaying all outstanding obligations under the Bridge Loan using a new 5-year $275.0 million senior secured revolving credit facility[414]. - For the fiscal year ended January 31, 2026, approximately 84% of the company's expenses were denominated in U.S. Dollars[417]. - Foreign currency gains and losses for the fiscal year ended January 31, 2026, included gains of $0.2 million and losses of $0.4 million for the years ended January 31, 2026 and 2025, respectively[418]. - The company entered into foreign currency forward contracts to hedge a portion of its Canadian Dollar denominated payroll payments, with 90% designated as a cash flow hedge[419]. - A 1% increase or decrease in foreign exchange rates between the Canadian Dollar, Indian Rupee, and U.S. Dollar is not expected to have a material effect on the company's results of operations or financial condition[420]. Technology and Innovation - The company integrates artificial intelligence into its solutions to enhance automation, personalization, and operational efficiency[36]. - Privacy and security are prioritized, with comprehensive measures in place to safeguard client data and compliance with industry standards[37]. Recognition and Awards - The company was recognized in multiple awards, including being named to the 2025 Deloitte Technology Fast 500 and TIME's 2025 World's Top HealthTech Companies list[67]. Investment Strategy - The company maintains a commitment to preserving principal while maximizing income through its investment activities, focusing on cash equivalents with short maturities[413].

Regulatory Approvals and Compliance - The CompuFlo Epidural System received FDA 510(k) clearance in 2017 for lumbar epidural injections, with expanded clearance in 2023 for the thoracic region [30]. - The CompuFlo Epidural System has been assigned a Category III CPT code (0777T) by the American Medical Association, effective January 1, 2023, to facilitate reimbursement [30]. - The company must obtain MDR certification for its Class IIa and Class IIb devices by December 31, 2028, to continue marketing in the EU [65]. - The FDA's new Quality Management System Regulation (QMSR) will become effective on February 2, 2026, aligning U.S. requirements with ISO 13485 [59]. - The FDA typically responds to 510(k) Pre-market Notification submissions within 180 days, but there is no specific time limit for their response [55]. Financial Performance and Challenges - The company has incurred significant operating losses of $5.7 million and $6.8 million for the years ended December 31, 2025, and 2024, respectively [73]. - Net cash used in operating activities was approximately $2.9 million for the years ended December 31, 2025, and 2024 [76]. - The company has substantial doubt about its ability to continue as a going concern without raising additional capital due to recurring losses and an accumulated deficit [81]. - The company reported total assets of approximately $7.8 million and working capital of approximately $3.3 million as of December 31, 2025 [149]. - The company has stockholders' equity of approximately $3.3 million, which does not meet the NYSE American listing requirements of $4 million or more [151]. Market and Sales Dynamics - In 2025, export sales outside the United States represented approximately 45% of total sales, with products sold in about 37 countries and U.S. territories [84]. - The company relies heavily on its E-Commerce platform for sales, which was launched in January 2023, and any failure to maintain or expand this platform could negatively impact sales [82][83]. - The CompuFlo Epidural System is expected to generate substantially all medical product revenues in the near term, and its market acceptance is critical for revenue generation [85]. - Domestic product sales in the US amounted to $4,969,215 in 2025, compared to $5,254,331 in 2024, indicating a decline of about 5.4% [206]. - International sales (Rest of World) increased to $3,694,767 in 2025 from $3,375,597 in 2024, reflecting a growth of approximately 9.4% [206]. Research and Development - The company has delayed all research and development on its next-generation Single Tooth Anesthesia System due to cash management concerns, which may hinder its ability to compete effectively [88]. - The company plans to transition from a research-and-development-focused organization to a commercially oriented medical device company following FDA clearance of its products [205]. - The company is delaying research and development activities related to the next-generation Single Tooth Anesthesia System instrument to manage costs [214]. Intellectual Property and Competition - The company holds approximately 305 issued U.S. and foreign patents, covering various proprietary technologies related to drug delivery [29]. - The proprietary DPS technology differentiates the company's products by providing continuous real-time pressure feedback during injections [49]. - The company may face challenges in protecting its intellectual property rights, which could adversely affect its ability to prevent competition in the anesthetic delivery systems market [104]. - The company faces risks related to intellectual property, including potential infringement claims that could require costly negotiations for licenses or redesigns [171]. Operational Risks and Management - The company relies on third-party manufacturers for production, which exposes it to risks related to supply disruptions and quality issues [38]. - The company has limited internal experience in manufacturing operations and lacks the resources to produce its products independently [107]. - The company has been supplied by its current manufacturers since 1998 and 2003, but the informal purchase order arrangements do not guarantee price protection or supply commitments [108]. - Quality management is critical for the company's success, and any quality or safety issues could lead to regulatory actions and loss of customer confidence [114]. - The company may encounter difficulties in establishing new manufacturing relationships, which could involve significant expenses and delays [117]. Cybersecurity and IT Risks - The company relies heavily on IT systems and cloud-based platforms, making it vulnerable to cybersecurity incidents that could materially impact its business [176]. - The company maintains a cybersecurity program that includes periodic risk assessments and employee training [187]. - The company has not identified any cybersecurity incidents that have materially affected its business strategy or financial condition [189]. Leadership and Governance - The company has appointed Eric Hines as President and CEO, replacing Arjan Haverhals, who retired at the end of 2024 [105]. - The company is required to develop and implement effective internal controls over financial reporting as mandated by the Sarbanes-Oxley Act, with any failure potentially harming investor confidence [157]. Future Outlook and Funding - The company anticipates needing additional funding for operations, which may affect its ability to continue research and development programs [76]. - The company may need additional financing to execute its business plan, which may not be available on reasonable terms [148]. - Management's assessment of the company's ability to continue as a going concern is based on estimates regarding future revenues and access to additional capital [212].

Revenue Concentration - For the year ended December 31, 2025, two customers accounted for 79% of consolidated revenue, all related to the Drone segment[205]. Financial Performance - The company incurred net losses of $4.1 million and $38.7 million for the years ended December 31, 2025 and 2024, respectively, with an accumulated deficit of $210.6 million as of December 31, 2025[199]. - The company may need to raise additional capital to support R&D and commercialization efforts, which could impact operations if financing is not obtained[203]. - The company’s estimates of the total addressable market for its products may be overly optimistic, potentially impairing sales growth and financial performance[251]. - The company may incur significant costs related to compliance with data privacy and security obligations, which could lead to financial losses and reputational harm[245]. - The company does not intend to pay dividends in the foreseeable future, limiting returns to stockholders to stock price appreciation[339]. Operating Expenses and Growth - The company expects to continue incurring significant operating expenses due to expansion of headcount and acceleration of product development[201]. - The company faces challenges in hiring skilled personnel, which may affect operational capabilities and growth plans[228]. - The company may struggle to maintain historical revenue and operating efficiency due to integration difficulties[216]. Supply Chain and Production Risks - The company relies on a limited number of suppliers in Canada and Europe for critical components, which poses risks to production[195]. - Supply chain issues, including inflation and supplier reliability, are expected to negatively impact operations through 2026[231]. - The company faces risks related to supply shortages of component parts, which could delay product development and delivery, potentially harming financial results[233]. - The company relies on third-party components, which may impact the success of future products if not procured timely[221]. Regulatory and Compliance Challenges - The company is subject to extensive government regulation, and failure to comply may result in significant financial liabilities[196]. - The company is subject to extensive U.S. government regulations, and non-compliance could lead to significant financial liabilities, penalties, and loss of contracts, adversely affecting business operations and financial condition[277]. - Compliance with local, state, federal, and international regulations is costly and could affect the ability to sell and manufacture products, impacting overall financial performance[294]. - The company is subject to stringent U.S. and foreign data privacy and security laws, with potential consequences for non-compliance including fines and reputational harm[301]. Market and Competitive Landscape - The defense and aerospace industry is highly competitive, with significant competition from companies with greater resources[217]. - The market for eVTOL aircraft is still emerging, and the company has not yet obtained FAA certification for its eVTOL aircraft under development[196]. - The electric air mobility market is still emerging and may not achieve expected growth, posing risks to the company's financial condition and operational results[252]. - Consumer adoption of eVTOL aircraft is uncertain, and reluctance to pay projected prices could harm the company's financial condition and operating results[255]. Acquisitions and Integration - The anticipated purchase price for two potential acquisitions in the Training segment is expected to range from $5.1 million to $7.7 million[210]. - The company has made acquisitions and may face challenges in integrating acquired businesses and realizing anticipated synergies[210]. - Integration of acquired companies may face challenges, potentially leading to unanticipated costs and failure to realize expected synergies[214]. - Acquired companies may have undiscovered liabilities, which could adversely impact financial performance[215]. Technological Development and Risks - The company is developing generative AI technologies, including AIRO Drone's DaaS and AIRO-NET, but faces regulatory and operational risks associated with these technologies[237]. - Technological advancements are critical, and failure to keep pace may adversely affect revenues and profitability[219]. - The company relies on third-party partners for emerging technologies, and there is no assurance that these technologies will be commercially viable or meet production requirements[267]. International Operations - A majority of total net sales in 2024 and 2025 were from international customers, highlighting the significance of international operations[297]. - International sales face substantial competition from both U.S. and foreign manufacturers, with risks including political and economic factors, currency fluctuations, and regulatory requirements[297]. - Direct commercial sales (DCS) transactions present higher risks due to less familiarity with international parties and differing local laws[299]. Internal Controls and Governance - The company has identified material weaknesses in internal control over financial reporting, which could affect the accuracy of financial reporting[205]. - The company has initiated measures to remediate material weaknesses, including hiring experienced accounting personnel and engaging an independent internal auditor[324]. - The independent registered public accounting firm will not formally attest to the effectiveness of internal controls until the company is no longer classified as an "emerging growth company" under SEC rules[332]. Risks from External Factors - Adverse weather and natural disasters can significantly disrupt operations, potentially affecting the company's financial results more than competitors[250]. - The company faces risks from geopolitical events and economic disruptions that could adversely affect market conditions and operations[300]. - The company may experience adverse consequences from cybersecurity threats, including data breaches and operational disruptions, which could impact revenue and reputation[239]. Stockholder and Management Dynamics - Significant stockholders and management hold a large percentage of voting stock, allowing them to influence major corporate decisions[340]. - The management team has limited experience managing a public company, which may affect operational efficiency and compliance with regulatory requirements[341]. - Future issuances of debt or equity securities may dilute existing stockholders and adversely affect the market price of common stock[342].